AGL has 36-month beta value of 0.67. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for AGL is 302.72M, and currently, short sellers hold a 14.58% ratio of that float. The average trading volume of AGL on August 12, 2024 was 4.49M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
AGL) stock’s latest price update
Agilon Health Inc (NYSE: AGL)’s stock price has plunge by -1.43relation to previous closing price of 5.60. Nevertheless, the company has seen a -12.93% plunge in its stock price over the last five trading sessions. globenewswire.com reported 2024-08-08 that NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. (NYSE: AGL) on behalf of long-term stockholders following a class action complaint that was filed against Agilon on March 19, 2024 with Class Period (1) Agilon common stock purchases traceable to the April 2021 initial public offering of Agilon stock; (2) pursuant, or traceable, or both, to materials issued in connection with the Company’s secondary public offering that occurred on or about May 16, 2023; and/or (3) common stock between April 15, 2021 and February 27, 2024. Our investigation concerns whether the board of directors of Agilon have breached their fiduciary duties to the company.
AGL’s Market Performance
Agilon Health Inc (AGL) has experienced a -12.93% fall in stock performance for the past week, with a -10.24% drop in the past month, and a 4.94% rise in the past quarter. The volatility ratio for the week is 9.31%, and the volatility levels for the past 30 days are at 7.86% for AGL. The simple moving average for the last 20 days is -17.72% for AGL stock, with a simple moving average of -30.11% for the last 200 days.
Analysts’ Opinion of AGL
Many brokerage firms have already submitted their reports for AGL stocks, with Robert W. Baird repeating the rating for AGL by listing it as a “Neutral.” The predicted price for AGL in the upcoming period, according to Robert W. Baird is $6 based on the research report published on May 30, 2024 of the current year 2024.
Citigroup, on the other hand, stated in their research note that they expect to see AGL reach a price target of $6. The rating they have provided for AGL stocks is “Neutral” according to the report published on April 22nd, 2024.
Barclays gave a rating of “Underweight” to AGL, setting the target price at $5 in the report published on March 06th of the current year.
AGL Trading at -15.28% from the 50-Day Moving Average
After a stumble in the market that brought AGL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -72.90% of loss for the given period.
Volatility was left at 7.86%, however, over the last 30 days, the volatility rate increased by 9.31%, as shares sank -12.24% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -4.17% lower at present.
During the last 5 trading sessions, AGL fell by -12.93%, which changed the moving average for the period of 200-days by -70.72% in comparison to the 20-day moving average, which settled at $6.67. In addition, Agilon Health Inc saw -56.02% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AGL starting from Schwaneke Jeffrey A., who purchase 22,300 shares at the price of $11.22 back on Nov 29 ’23. After this action, Schwaneke Jeffrey A. now owns 31,931 shares of Agilon Health Inc, valued at $250,206 using the latest closing price.
Shaker Benjamin, the Chief Markets Officer of Agilon Health Inc, sale 18,750 shares at $18.00 during a trade that took place back on Sep 13 ’23, which means that Shaker Benjamin is holding 79,543 shares at $337,455 based on the most recent closing price.
Stock Fundamentals for AGL
Current profitability levels for the company are sitting at:
- -0.05 for the present operating margin
- 0.0 for the gross margin
The net margin for Agilon Health Inc stands at -0.05. The total capital return value is set at -0.34. Equity return is now at value -29.03, with -10.01 for asset returns.
Based on Agilon Health Inc (AGL), the company’s capital structure generated 0.05 points at debt to capital in total, while cash flow to debt ratio is standing at -3.9. The debt to equity ratio resting at 0.05. The interest coverage ratio of the stock is -80.63.
Currently, EBITDA for the company is -211.78 million with net debt to EBITDA at 0.32. When we switch over and look at the enterprise to sales, we see a ratio of 0.41. The receivables turnover for the company is 3.73for trailing twelve months and the total asset turnover is 2.48. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.36.
Conclusion
To put it simply, Agilon Health Inc (AGL) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
